Search
Powered By HealthLine
Special Offers
Health Tools
 Mammogram Guide
 Check A Breast Cancer Symptom
 Understanding Skin Cancer
 Skin Cancer Q&A
 Prostate Cancer Treatment
Featured Conditions
 Breast Cancer
 Skin Cancer
 Prostate
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Some Hiroshima Survivors at Thyroid Cancer Risk


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Basal Cell Carcinoma
Bladder Cancer
Bone Cancer
More...

Related Healthscout Videos
 border=
Silent Killer
Sun Damaged
Complementary Cancer Care
A Welcome Message from Survivor PJ Hamel
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
More...

Related Drug Information
 border=
Epogen
Iressa
Procrit
Topamax
More...

Related News Articles
 border=
Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk
Drinking Moderately or More Ups Men's Cancer Risk
Living in U.S. May Raise Hispanics' Cancer Risk
Many Texas Docs Not Pushing HPV Vaccine for Girls
More...


Page:  << Prev | 1 | 2

In their study, Hamatani's team found that between 1958 and 1998, there were 63 cases of thyroid cancer attributable to A-bomb radiation exposure, of which 90 percent were of the papillary variety.

They also extracted genetic material called RNA from thyroid tissue samples supplied by 50 patients who had been exposed to atomic bomb radiation, along with 21 patients who were not exposed.

The comparative genetic profiles revealed that younger men and women who lived close to the bomb site when exposed to radioactive fallout, and who went on to develop PTC, were more likely to have the less frequent chromosomal rearrangement.

Text Continues Below



Hamatani cautioned, however, that he and his colleagues still do not know exactly how radiation exposure might have contributed to the onset of RET/PET rearrangements. It's even possible that radiation exposure may not have played a role in the development of PTC among patients who had the chromosomal rearrangement before they were diagnosed with the disease. Hamatani noted that, among childhood PTC cases in particular, such chromosomal shifts are relatively common, regardless of whether a child has been exposed to radiation or not.

Because of this, Hamatani stressed that any link between radiation and chromosomal changes, "needs to be confirmed with additional PTC patients in the future".

In the meantime, Dr. Alfred I. Neugut, a professor of medicine and epidemiology at Columbia University College of Physicians and Surgeons, and co-director of cancer prevention at New York Presbyterian Hospital, in New York City, said the association "makes biological sense."

"The fact that radiation exposure is associated with thyroid cancer is well known and not news," he noted. "But now, as research technology has caught up with scientific expectations, they're now able to identify the specific chromosomal anomaly that causes the cancer. And, indeed, this is exactly what you would expect."

More information

For more about radiation and its impact on health, visit the U.S. Nuclear Regulatory Commission.

Page:  << Prev | 1 | 2

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 8/29/2008

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Kiyohiro Hamatani, Ph.D., chief, laboratory of cell biology, department of radiobiology/molecular epidemiology, Radiation Effects Research Foundation (RERF), Hiroshima, Japan; Alfred I. Neugut, M.D., Ph.D., professor of medicine and epidemiology, Columbia University College of Physicians and Surgeons, and co-director of cancer prevention, New York Presbyterian Hospital, New York City; Sept. 1, 2008, Cancer Research


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy